Stocktoria
ZeroStack Corp. ZSTK
Nasdaq · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2021-05-11 · LEI
ZeroStack Corp. financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $35.7M | $35.9M | $76.1M | $33.4M | $9.0M |
| Gross profit | $1.6M | $2.2M | $17.7M | $13.3M | $2.4M |
| R&D expense | — | $418,000 | $62,000 | $388,000 | $132,000 |
| Operating income | -$154.7M | -$8.9M | -$50.4M | -$47.2M | -$19.0M |
| Income tax | $59,000 | $22,000 | -$1.6M | -$1.4M | -$98,000 |
| Net income | — | -$15.9M | -$57.0M | -$52.4M | -$21.4M |
| EPS (diluted) | $-43.49 | $-50.02 | $-7.75 | $-13.68 | — |
| Operating cash flow | -$8.7M | -$5.0M | -$8.4M | -$15.9M | -$20.9M |
| Free cash flow | -$8.8M | -$5.2M | -$8.6M | -$17.2M | -$24.9M |
| Cash & equivalents | $5.6M | $5.2M | $4.3M | $8.9M | $37.6M |
| Inventory | $1.9M | $2.2M | $8.5M | $8.7M | $3.0M |
| Total assets | $130.2M | $26.2M | $23.6M | $81.0M | $85.5M |
| Total liabilities | $59.7M | $21.7M | $17.2M | $24.6M | $8.5M |
| Shareholders' equity | $70.6M | $4.5M | $6.4M | $56.8M | $77.2M |
Growth · year-over-year · Revenue CAGR 41.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -0.5% | -52.9% | +127.8% | +271.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.